Sebastian Sanchez

Sebastian Sanchez

Auto-generated profile, based on publicly available information

Sebastian Sanchez

Neurology, University of Iowa, Iowa City, IA, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2022 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Open access
PDF file
SSSebastian Sanchez
Sebastian Sanchez
ARAshrita Raghuram
Ashrita Raghuram
LWLinder Wendt
Linder Wendt
MHMinako Hayakawa
Minako Hayakawa
CCChing-Jen Chen
Ching-Jen Chen
ESEdgar A Samaniego
Edgar A Samaniego
Background Anterior cranial fossa dural arteriovenous fistulas (ACF-dAVFs) are aggressive vascular lesions. The pattern of venous drainage is the most important determinant of symptoms. Due to the absence of a venous sinus in the anterior cranial fossa, most ACF-dAVFs have some degree of drainage through small cortical veins. We describe the natural history, angiographic presentation and outcomes of the largest cohort of ACF-dAVFs. Methods The CONDOR consortium includes data from 12 international centers. Patients included in the study were diagnosed with an arteriovenous fistula between 1990–2017. ACF-dAVFs were selected from a cohort of 1077 arteriovenous fistulas. The presentation, angioarchitecture and treatment outcomes of ACF-dAVF were extracted and analyzed. Results 60 ACF-dAVFs were included in the analysis. Most ACF-dAVFs were symptomatic (38/60, 63%). The most common symptomatic presentation was intracranial hemorrhage (22/38, 57%). Most ACF-dAVFs drained through cortical veins (85%, 51/60), which in most instances drained into the superior sagittal sinus (63%, 32/51). The presence of cortical venous drainage predicted symptomatic presentation (OR 9.4, CI 1.98 to 69.1, p=0.01). Microsurgery was the most effective modality of treatment. 56% (19/34) of symptomatic patients who were treated had complete resolution of symptoms. Improvement of symptoms was not observed in untreated symptomatic ACF-dAVFs. Conclusion Most ACF-dAVFs have a symptomatic presentation. Drainage through cortical veins is a key angiographic feature of ACF-dAVFs that accounts for their malignant course. Microsurgery is the most effective treatment. Due to the high risk of bleeding, closure of ACF-dAVFs is indicated regardless of presentation.

11 August 2022 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
SSS. Sanchez
S. Sanchez
ARA. Raghuram
A. Raghuram
RFR. Fakih
R. Fakih
LWLinder Wendt
Linder Wendt
GBG. Bathla
G. Bathla
ESEdgar A Samaniego
Edgar A Samaniego
BACKGROUND AND PURPOSE: High-resolution MR imaging allows the identification of culprit symptomatic plaques after the administration of gadolinium. Current high-resolution MR imaging methods are limited by 2D multiplanar views and manual sampling of ROIs. We analyzed a new 3D method to objectively quantify gadolinium plaque enhancement. MATERIALS AND METHODS: Patients with stroke due to intracranial atherosclerotic disease underwent 7T high-resolution MR imaging. 3D segmentations of the plaque and its parent vessel were generated. Signal intensity probes were automatically extended from the lumen into the plaque and the vessel wall to generate 3D enhancement color maps. Plaque gadolinium (Gd) uptake was quantified from 3D color maps as gadolinium uptake = (µPlaque T1 + Gd −µPlaque T1/SDPlaque T1). Additional metrics of enhancement such as enhancement ratio, variance, and plaque-versus-parent vessel enhancement were also calculated. Conventional 2D measures of enhancement were collected for comparison. RESULTS: Thirty-six culprit and 44 nonculprit plaques from 36 patients were analyzed. Culprit plaques had higher gadolinium uptake than nonculprit plaques (P < .001). Gadolinium uptake was the most accurate metric for identifying culprit plaques (OR, 3.9; 95% CI 2.1–8.3). Gadolinium uptake was more sensitive (86% versus 70%) and specific (71% versus 68%) in identifying culprit plaques than conventional 2D measurements. A multivariate model, including gadolinium uptake and plaque burden, identified culprit plaques with an 83% sensitivity and 86% specificity. CONCLUSIONS: The new 3D color map method of plaque-enhancement analysis is more accurate for identifying culprit plaques than conventional 2D methods. This new method generates a new set of metrics that could potentially be used to assess disease progression.

1 June 2025 in Stroke
Verified
Journal Article
Closed access
DMDaniel Mandel
Daniel Mandel
LSLiqi Shu
Liqi Shu
CCChristopher Chang
Christopher Chang
NJNaomi Jack
Naomi Jack
CGChristopher R. Leon Guerrero
Christopher R. Leon Guerrero
SYShadi Yaghi
Shadi Yaghi
BACKGROUND: Patients presenting with cervical artery dissection (CAD) are at risk for subsequent ischemic events. We aimed to identify characteristics that are associated with increased risk of ischemic stroke after initial presentation of CAD and to evaluate the differential impact of anticoagulant versus antiplatelet therapy in these high-risk individuals. METHODS: This was a preplanned secondary analysis of the STOP-CAD study (Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection), a multicenter international retrospective observational study (63 sites from 16 countries in North America, South America, Europe, Asia, and Africa) that included patients with CAD predominantly between January 2015 and June 2022. The primary outcome was subsequent ischemic stroke by day 180 after diagnosis. Clinical and imaging variables were compared between those with versus without subsequent ischemic stroke. Significant factors associated with subsequent stroke risk were identified using stepwise Cox regression. Associations between subsequent ischemic stroke risk and antithrombotic therapy type (anticoagulation versus antiplatelets) among patients with identified risk factors were explored using adjusted Cox regression. RESULTS: In all, 4023 patients (mean age was 47.4 years; 44.5% were women) were included. By day 180, subsequent ischemic stroke occurred in 5.3% of the cohort. In adjusted Cox regression, factors associated with increased risk of subsequent ischemic stroke were prior history of ischemic stroke (adjusted hazard ratio [aHR], 7.31 [95% CI, 1.61–33.13]; P =0.010), presentation within 7 days from first symptoms (aHR, 3.04 [95% CI, 1.04–8.91]; P =0.043), infarct on baseline imaging (aHR, 9.85 [95% CI, 3.65–26.58]; P <0.001), and occlusive dissection (aHR, 2.34 [95% CI, 1.03–5.34]; P =0.043). Only patients with occlusive dissection demonstrated a reduced risk of subsequent ischemic stroke when treated with anticoagulation versus antiplatelets (aHR, 0.36 [95% CI, 0.16–0.80]; P =0.01). CONCLUSIONS: In this post hoc analysis of the STOP-CAD study, several factors associated with subsequent ischemic stroke were identified among patients with CAD. Furthermore, we identified a potential benefit of anticoagulation in patients with CAD with occlusive dissection. These findings require validation by meta-analyses of prior studies to formulate optimal treatment strategies for specific high-risk CAD subgroups.

30 July 2023
Verified
Conference Paper
Open access
PDF file
DOD Ojeda
D Ojeda
SSS Sanchez
S Sanchez
JMJ Miller
J Miller
MAM Almajali
M Almajali
PKP Koul
P Koul
ESEdgar A Samaniego
Edgar A Samaniego
Introduction The Tigertriver allows the operator to control the radial expansion inside the target vessel. The increased radial force of Tigertriever may provide a more effective thrombectomy in patients with acute ischemic stroke (AIS) due to intracranial atherosclerotic disease (ICAD). We analyzed data from the TIGER trial1 to determine the safety and effectiveness of Tigertriever in patients with ICAD. Methods Computed tomography angiography, and digital subtraction angiography of patients enrolled in the TIGER trial who had underlying ICAD were analyzed by a blinded core laboratory. Underlying ICAD at the large vessel occlusion was adjudicated by two independent investigators. In case of discrepancy, a third senior investigator served as adjudicator. Successful reperfusion was defined as TICI 2b-3 within three passes (figure 1). Only patients who did not require rescue therapy with other devices were included in the analysis to decrease cofounders. Results One-hundred sixty patients who were included in the TIGER trial were analyzed. Twenty percent (32/160) of patients were determined to have underlying ICAD that may have contributed to the occlusion due to stenosis or was the primary etiology for the large vessel occlusion. Twenty-three (23/32, 72%) patients with ICAD achieved successful reperfusion within 3 passes; the rest required rescue treatment with ancillary devices. Baseline NIHSS score was 16.5 (IQR=7) and median baseline ASPECT score was 9 (IQR=1). Tigetriever had a higher successful reperfusion rate within the first 3 passes (72%) compared to other studies with other stentrievers (63%-65). An increase in the proximal diameter of the occluded vessel was seen after thrombectomy (1.55 ± 0.74 versus 1.86 ± 0.7, p < 0.001). No symptomatic intracranial hemorrhages were observed while asymptomatic intracranial hemorrhage at 24 hours occurred in 17.4% (4/23) of patients. No procedural complications were reported. The NIHSS at 24-hours was 7.95 ± 7.12, and mortality rate for any cause at 3 months was 21.74% (5/23). At three months, 68% (14/23) of patients achieved a mRS score of < 2, compared to historical controls with other stentrievers (42.4% (15/36); 42% (10/24). Conclusion Tigertriever exerts a higher radial force that can be manually tailored to achieve better recanalization in patients with LVO due to ICAD. Reference Gupta R, Saver JL, Levy E, et al. New class of radially adjustable stentrievers for acute ischemic stroke: primary results of the multicenter TIGER trial. Stroke. May 2021;52(5):1534-1544. doi:10.1161/strokeaha.121.034436 (A) A right Ml occlusion due to underlying ICAD (arrowhead). (B) The Tigertriever is deployed across the stenosis. The device ‘massages’ the thrombus and exerts an increased radial force in stenotic lesions due to ICAD (arrowhead). (C) Recanalization with mild residual stenosis (arrowhead) Disclosures D. Ojeda: None. S. Sanchez: None. J. Miller: None. M. Almajali: None. P. Koul: None. L. Noboa: None. M. Ghannam: None. E. Samaniego: None.

30 July 2023
Verified
Conference Paper
Open access
PDF file
SSS Sanchez
S Sanchez
MEM Essibayi
M Essibayi
MHM Hickerson
M Hickerson
DOD Ojeda
D Ojeda
SKS Al Kasab
S Al Kasab
ESEdgar A Samaniego
Edgar A Samaniego
Background Age is a risk determinant in various clinical scales. Current knowledge about the morphology of ruptured aneurysms of patients of varying ages is limited. We present a multicenter study that aimed at determining age-dependent morphological characteristics of brain aneurysms. Methods Unruptured and ruptured saccular aneurysms from the STAR registry were evaluated. Our analysis consisted of location, size, neck, width, height, aspect ratio, and regular versus irregular morphology. Logistic regression was utilized to estimate the risk of rupture presentation. Results A total of 1407 unruptured and 607 ruptured aneurysms were included. The MCA and ACOM were the most common locations for ruptured aneurysms in patients younger than 70 years. Conversely, ACOM and PCOM were the most common locations for ruptured aneurysms in patients older than 70 years-old. The size of unruptured aneurysms increased among age groups (p < .001). However, size was similar among ruptured aneurysms of different age groups (p = .142). Unruptured and ruptured aneurysms became more irregular with age (p < .001 and p .025, respectively). Finally,ruptured aneurysms were more likely to be irregular in all age groups: 20-50 (OR = 3.9, 95% CI [2.0-4.7]); 51 -70 (OR = 1.9, 95% CI [1.5-2.6]); and 71-100 (OR = 3.4, 91% CI [2.2-5.4]). Conclusion The morphology of saccular brain aneurysms is different among age groups. An irregular morphology is a high-risk feature regardless of age. In younger patients, aneurysms are smaller, tend to be more regular and ruptured aneurysms are mostly located in the MCA and ACOM. In older patients, aneurysms are larger, have a more irregular morphology and ruptured aneurysms are mostly located in the PCOM and ACOM. Disclosures S. Sanchez: None. M. Essibayi: None. M. Hickerson: None. D. Ojeda: None. S. Al Kasab: None. S. Yoshimura: None. P. Jabbour: None. J. Mascitelli: None. M. Levitt: None. H. Cuellar-Saenz: None. W. Brinjikji: None. A. Spiotta: None. A. Shaban: None. E. Samaniego: None.

10 August 2024 in medRxiv
Verified
Preprint
Open access
PDF file
DMDaniel Mandel
Daniel Mandel
LSLiqi Shu
Liqi Shu
CCChristopher Chang
Christopher Chang
NJNaomi Jack
Naomi Jack
CGChristopher R. Leon Guerrero
Christopher R. Leon Guerrero
SYShadi Yaghi
Shadi Yaghi
Objective Patients with cervical artery dissection (CAD) are at increased ischemic stroke risk. We aimed to identify characteristics that are associated with increased risk of ischemic stroke following initial presentation of CAD and to evaluate the differential impact of anticoagulant versus antiplatelet therapy in these high-risk individuals. Methods This was a secondary analysis of the Antithrombotic Treatment for Stroke Prevention in Cervical Artery Dissection (STOP-CAD) study, a multicenter retrospective observational study. The primary outcome was subsequent ischemic stroke by day 180 after diagnosis. Patient characteristics were compared between those with vs. without subsequent ischemic stroke. Significant predictors were identified using stepwise Cox regression. Associations between subsequent ischemic stroke risk and antithrombotic therapy type in high-risk patients were explored using adjusted Cox regression. Results 4,023 patients (mean age 47.4 years; 44.5% were women) were included. By day 180, 5.3% experienced a subsequent ischemic stroke. In adjusted Cox regression, factors associated with increased subsequent ischemic stroke risk were prior ischemic stroke (aHR 7.31, 95% CI 1.61-33.13, p=0.010), presentation within seven days from symptoms, (aHR 3.04, 95% CI 1.04-8.91, p=0.043), infarct on imaging (aHR 9.85, 95% CI 3.65-26.58, p<0.001), and occlusive dissection (aHR 2.34, 95% CI 1.03-5.34, p=0.043). Only patients with occlusive dissection had reduced subsequent ischemic stroke risk with anticoagulation versus antiplatelets (HR 0.37; 95% CI 0.15-0.89, p=0.03). Interpretation This study identified several predictors of subsequent ischemic stroke among patients with CAD but only patients with occlusive dissection demonstrated a benefit from anticoagulation. These findings require validation by meta-analyses of prior studies.